
The global Serum Replacement market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Serum Replacement, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Serum Replacement.
Report Scope
The Serum Replacement market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Serum Replacement market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Serum Replacement companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Pall
Sartorius
Cytiva
PAN-Biotech
Biowest
VWR
Segment by Type
Embryonic Stem Cells
Induced Pluripotent Stem Cells
Other
Segment by Application
Scientific Research
Pharmaceutical Manufacturing
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Serum Replacement companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Serum Replacement Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Embryonic Stem Cells
1.2.3 Induced Pluripotent Stem Cells
1.2.4 Other
1.3 Market by Application
1.3.1 Global Serum Replacement Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Scientific Research
1.3.3 Pharmaceutical Manufacturing
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Serum Replacement Market Perspective (2019-2030)
2.2 Serum Replacement Growth Trends by Region
2.2.1 Global Serum Replacement Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Serum Replacement Historic Market Size by Region (2019-2024)
2.2.3 Serum Replacement Forecasted Market Size by Region (2025-2030)
2.3 Serum Replacement Market Dynamics
2.3.1 Serum Replacement Industry Trends
2.3.2 Serum Replacement Market Drivers
2.3.3 Serum Replacement Market Challenges
2.3.4 Serum Replacement Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Serum Replacement Players by Revenue
3.1.1 Global Top Serum Replacement Players by Revenue (2019-2024)
3.1.2 Global Serum Replacement Revenue Market Share by Players (2019-2024)
3.2 Global Serum Replacement Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Serum Replacement Revenue
3.4 Global Serum Replacement Market Concentration Ratio
3.4.1 Global Serum Replacement Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Serum Replacement Revenue in 2023
3.5 Serum Replacement Key Players Head office and Area Served
3.6 Key Players Serum Replacement Product Solution and Service
3.7 Date of Enter into Serum Replacement Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Serum Replacement Breakdown Data by Type
4.1 Global Serum Replacement Historic Market Size by Type (2019-2024)
4.2 Global Serum Replacement Forecasted Market Size by Type (2025-2030)
5 Serum Replacement Breakdown Data by Application
5.1 Global Serum Replacement Historic Market Size by Application (2019-2024)
5.2 Global Serum Replacement Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Serum Replacement Market Size (2019-2030)
6.2 North America Serum Replacement Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Serum Replacement Market Size by Country (2019-2024)
6.4 North America Serum Replacement Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Serum Replacement Market Size (2019-2030)
7.2 Europe Serum Replacement Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Serum Replacement Market Size by Country (2019-2024)
7.4 Europe Serum Replacement Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Serum Replacement Market Size (2019-2030)
8.2 Asia-Pacific Serum Replacement Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Serum Replacement Market Size by Region (2019-2024)
8.4 Asia-Pacific Serum Replacement Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Serum Replacement Market Size (2019-2030)
9.2 Latin America Serum Replacement Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Serum Replacement Market Size by Country (2019-2024)
9.4 Latin America Serum Replacement Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Serum Replacement Market Size (2019-2030)
10.2 Middle East & Africa Serum Replacement Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Serum Replacement Market Size by Country (2019-2024)
10.4 Middle East & Africa Serum Replacement Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Serum Replacement Introduction
11.1.4 Thermo Fisher Scientific Revenue in Serum Replacement Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Pall
11.2.1 Pall Company Detail
11.2.2 Pall Business Overview
11.2.3 Pall Serum Replacement Introduction
11.2.4 Pall Revenue in Serum Replacement Business (2019-2024)
11.2.5 Pall Recent Development
11.3 Sartorius
11.3.1 Sartorius Company Detail
11.3.2 Sartorius Business Overview
11.3.3 Sartorius Serum Replacement Introduction
11.3.4 Sartorius Revenue in Serum Replacement Business (2019-2024)
11.3.5 Sartorius Recent Development
11.4 Cytiva
11.4.1 Cytiva Company Detail
11.4.2 Cytiva Business Overview
11.4.3 Cytiva Serum Replacement Introduction
11.4.4 Cytiva Revenue in Serum Replacement Business (2019-2024)
11.4.5 Cytiva Recent Development
11.5 PAN-Biotech
11.5.1 PAN-Biotech Company Detail
11.5.2 PAN-Biotech Business Overview
11.5.3 PAN-Biotech Serum Replacement Introduction
11.5.4 PAN-Biotech Revenue in Serum Replacement Business (2019-2024)
11.5.5 PAN-Biotech Recent Development
11.6 Biowest
11.6.1 Biowest Company Detail
11.6.2 Biowest Business Overview
11.6.3 Biowest Serum Replacement Introduction
11.6.4 Biowest Revenue in Serum Replacement Business (2019-2024)
11.6.5 Biowest Recent Development
11.7 VWR
11.7.1 VWR Company Detail
11.7.2 VWR Business Overview
11.7.3 VWR Serum Replacement Introduction
11.7.4 VWR Revenue in Serum Replacement Business (2019-2024)
11.7.5 VWR Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Thermo Fisher Scientific
Pall
Sartorius
Cytiva
PAN-Biotech
Biowest
VWR
Ìý
Ìý
*If Applicable.
